3.7 Analgesics and Vasoactive Sedative Titration

Analgesics and Vasoactive Sedative Titration

Post-intubation care in critical care transport requires a structured, goal-directed approach to analgesia and sedation, commonly referred to as "analgosedation." Managing a patient on a mechanical ventilator during flight involves mitigating the noxious stimuli of the transport environment, which includes continuous engine vibration, G-forces, altitude changes, and high decibel noise. Proper sedation and pain management prevent ventilator dyssynchrony, accidental extubation, and secondary physiological damage (such as hypertension, tachycardia, and elevated ICP).

The Analgosedation Philosophy

Analgosedation prioritizing pain control before administering sedatives is the modern standard of care. Critically ill patients on mechanical ventilation often experience pain that is misidentified as agitation. Administering sedatives without adequate analgesia can mask pain expression while causing hemodynamic instability.

To assess pain and sedation levels objectively in non-verbal, ventilated patients, transport crews utilize validated scoring systems:

• Critical-Care Pain Observation Tool (CPOT): Scores pain from 0 to 8 based on facial expression, body movements, muscle tension, and compliance with the ventilator. A score of 3 or higher indicates significant pain requiring analgesia.
• Richmond Agitation-Sedation Scale (RASS): A 10-point scale ranging from +4 (combative) to -5 (unarousable). The standard target for transport patients is light sedation, typically a RASS of -1 to -2. Deeper sedation (RASS -4 to -5) is reserved for patients with severe ARDS requiring paralytics, status epilepticus, or severe traumatic brain injury with intracranial hypertension.

Analgesic Pharmacology

Opioids are the primary class of medications used for analgesia in transport.

• Fentanyl (Sublimaze): Fentanyl is a synthetic, highly lipophilic opioid agonist acting on mu-receptors. It is the analgesic of choice in transport due to its rapid onset (1-2 minutes), short duration (30-60 minutes), and lack of active metabolites.
  • Dosing: Bolus: 0.5 to 2.0 mcg/kg IV/IO. Continuous Infusion: 0.5 to 3.0 mcg/kg/hr.
  • Hemodynamics: Fentanyl does not trigger histamine release, making it hemodynamically stable and safe for patients in shock or with borderline blood pressures.
• Morphine and Hydromorphone: These are less preferred in transport. Morphine causes histamine release, leading to systemic vasodilation and hypotension. Both medications have active metabolites that accumulate in patients with renal impairment, leading to prolonged sedation.

Sedative Infusions and Titration

Once analgesia is optimized, sedatives are titrated to achieve the target RASS score.

• Propofol (Diprivan): Propofol is an ultra-short-acting GABA-A receptor agonist that provides rapid sedation, amnesia, and anticonvulsant effects. It decreases ICP, cerebral blood flow, and $CMRO_2$.
  • Dosing: Continuous Infusion: 5 to 80 mcg/kg/min IV/IO. Boluses are generally avoided in transport due to severe hypotension.
  • Hemodynamics: Propofol causes significant systemic vasodilation and myocardial depression. Flight paramedics must be prepared to support hemodynamics with IV fluid boluses or vasoactive infusions (e.g., Norepinephrine).
  • Propofol Infusion Syndrome (PRIS): A rare, life-threatening complication associated with prolonged (>48 hours) or high-dose (>83 mcg/kg/min or >5 mg/kg/hr) infusions. Signs of PRIS include severe refractory metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney injury, hyperlipidemia, hepatomegaly, and progressive cardiac failure manifesting as bradyarrhythmias progressing to asystole.
• Dexmedetomidine (Precedex): Dexmedetomidine is a selective alpha-2 adrenergic agonist. It provides "cooperative sedation," allowing patients to be easily aroused to participate in neurological assessments. It does not cause respiratory depression.
  • Dosing: Continuous Infusion: 0.2 to 1.5 mcg/kg/hr. Loading doses (typically 1 mcg/kg over 10 minutes) are omitted in transport to prevent severe bradycardia and hypotension.
  • Hemodynamics: It can cause significant bradycardia and hypotension via its central sympatholytic effect.
• Midazolam (Versed): Midazolam is a benzodiazepine infusion used for amnesia and sedation.
  • Dosing: Continuous Infusion: 0.02 to 0.1 mg/kg/hr.
  • Clinical Profile: It has a high lipophilicity but accumulates in peripheral tissues (especially in obese patients) and has active renal-cleared metabolites, leading to unpredictable, prolonged sedation times. It is associated with higher rates of ICU delirium.

Hemodynamic Interactions and Titration Protocols

Vasoactive sedatives like propofol and dexmedetomidine frequently induce hypotension. In flight, this must be managed systematically:

1. Assess Volume Status: Ensure the patient is euvolemic. Fluid resuscitation should precede or accompany sedative initiation.
2. Titration: Adjust the sedative infusion by 5-10 mcg/kg/min (for propofol) every 5-10 minutes until the RASS goal is met.
3. Vasoactive Support: If hypotension occurs despite euvolemia and appropriate titration, initiate a vasopressor. Norepinephrine is the first-line vasopressor, titrated starting at 0.02 to 0.1 mcg/kg/min to maintain a Mean Arterial Pressure (MAP) of 65 mmHg or higher (or 80 mmHg or higher in acute traumatic brain injury).